Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization

There has been an explosion in scientific interest in using human-platelet-rich plasma (PRP) as a substitute of xenogeneic sera in cell-based therapies. However, there is a need to create standardization in this field. This systematic review is based on literature searches in PubMed and Web of Scien...

Descripción completa

Detalles Bibliográficos
Autores principales: Anitua, Eduardo, Zalduendo, Mar, Troya, Maria, Alkhraisat, Mohammad H., Blanco-Antona, Leticia Alejandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223511/
https://www.ncbi.nlm.nih.gov/pubmed/35742995
http://dx.doi.org/10.3390/ijms23126552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223511/
https://www.ncbi.nlm.nih.gov/pubmed/35742995
http://dx.doi.org/10.3390/ijms23126552

Ejemplares similares